Confounding Factors of Impedance Pneumography

May 20, 2019 updated by: Revenio Research

Confounding Factors of Impedance Pneumography Signal Changes During Sleep

The purpose of this study is to evaluate the association of signals recorded and analysed with Ventica® Lung Function Testing System (LFTS) in infants and pre-schoolers during the whole night sleep with the gold standard for sleep recording events, polysomnography, in order to better understand the confounding factors for momentary changes in the impedance pneumography-derived tidal breathing flow-volume (TBFV) curves.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zagreb, Croatia, 10000
        • Children's Hospital Srebrnjak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 7 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects referred to sleep laboratory at the investigational site or healthy volunteers from Zagreb and surroundings

Description

Group 1: (children referred to sleep study for clinical reasons) Inclusion criteria:

  • Age 1-7 years, both sexes
  • Referred to polysomnography
  • Signed informed consent

Group 2: (healthy children) Inclusion criteria:

  • 2-7 years, both sexes
  • Healthy at the time of inclusion based on history and clinical examination according to the investigator judgement
  • Lung function in the reference range
  • Signed informed consent

Exclusion Criteria:

  • Preterm birth with chronic respiratory disorder of prematurity
  • Significant nasal congestion or adenotonsillar hypertrophy with signs and symptoms of sleep apnea or sleep disordered breathing
  • Chronic rhinosinusitis, synonasal polyposis
  • Personal or family history or clinical evidence of asthma, atopy or other chronic respiratory disorders (high risk for asthma and allergy)
  • Use of asthma rescue or maintenance medication within 4 weeks prior to inclusion
  • Recurrent bronchitis or recurrent hospitalizations because of a respiratory illness (recurrent pneumonia)
  • Hospital-treated for bronchiolitis with residual symptoms
  • Acute respiratory infection or hospitalization because of an acute illness within 4 weeks prior to inclusion
  • Other cardiorespiratory or neurological chronic diseases or states that may significantly alter the overnight breathing pattern
  • Implanted or external active medical devices
  • Long lasting respiratory events during the polysomnography study like continuous upper airway limitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Sleep study for clinical reasons
Children referred to sleep study for clinical reasons
Healthy
Healthy children, no relevant pathologies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between sleep stages and tidal breathing flow-volume (TBFV) curves
Time Frame: 1 night
Assess the correlation between Ventica-derived TBFV curves within and between different EEG-derived sleep stages during night sleep
1 night

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between body/head positions and tidal breathing flow-volume (TBFV) curves
Time Frame: 1 night
Assess the correlation between Ventica-derived TBFV curves within and between different body/head positions (derived from video and/or positional sensors) during night sleep
1 night

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Davor Plavec, MD, PhD, Children's Hospital Srebrnjak

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2018

Primary Completion (Actual)

December 27, 2018

Study Completion (Actual)

December 27, 2018

Study Registration Dates

First Submitted

January 16, 2018

First Submitted That Met QC Criteria

January 23, 2018

First Posted (Actual)

January 24, 2018

Study Record Updates

Last Update Posted (Actual)

May 21, 2019

Last Update Submitted That Met QC Criteria

May 20, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe